<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>2 | Mary Ryan Baumann</title><link>https://maryryan.netlify.app/publication-type/2/</link><atom:link href="https://maryryan.netlify.app/publication-type/2/index.xml" rel="self" type="application/rss+xml"/><description>2</description><generator>Wowchemy (https://wowchemy.com)</generator><language>en-us</language><copyright>© Mary Ryan Baumann 2025</copyright><lastBuildDate>Thu, 27 Feb 2025 00:00:00 +0000</lastBuildDate><image><url>https://maryryan.netlify.app/media/icon_hu885146a88f720ebbe3814c746cadef9e_9536_512x512_fill_lanczos_center_2.png</url><title>2</title><link>https://maryryan.netlify.app/publication-type/2/</link></image><item><title>Impact of Study Partner Replacement in Mild Cognitive Impairment Clinical Trials</title><link>https://maryryan.netlify.app/publication/dolmadjian-sp-replacement-2025/</link><pubDate>Thu, 27 Feb 2025 00:00:00 +0000</pubDate><guid>https://maryryan.netlify.app/publication/dolmadjian-sp-replacement-2025/</guid><description/></item><item><title>A review of current practice in the design and analysis of extremely small stepped-wedge cluster randomized trials</title><link>https://maryryan.netlify.app/publication/tong-small-sw-crt-review-2024/</link><pubDate>Tue, 08 Oct 2024 00:00:00 +0000</pubDate><guid>https://maryryan.netlify.app/publication/tong-small-sw-crt-review-2024/</guid><description/></item><item><title>Power calculation for cross-sectional stepped wedge cluster randomized trials with a time-to-event endpoint</title><link>https://maryryan.netlify.app/publication/ryan-survivalswd-2024/</link><pubDate>Wed, 20 Dec 2023 00:00:00 +0000</pubDate><guid>https://maryryan.netlify.app/publication/ryan-survivalswd-2024/</guid><description/></item><item><title>Group sequential two-stage preference designs</title><link>https://maryryan.netlify.app/publication/liu-gs-tspd-2023/</link><pubDate>Mon, 27 Nov 2023 00:00:00 +0000</pubDate><guid>https://maryryan.netlify.app/publication/liu-gs-tspd-2023/</guid><description/></item><item><title>Adherence to key recommendations for design and analysis of stepped-wedge cluster randomized trials - A review of trials published 2016–2022</title><link>https://maryryan.netlify.app/publication/nevins-sw-crt-review2-2023/</link><pubDate>Tue, 21 Nov 2023 00:00:00 +0000</pubDate><guid>https://maryryan.netlify.app/publication/nevins-sw-crt-review2-2023/</guid><description/></item><item><title>ORTH.Ord - An R package for analyzing correlated ordinal outcomes using alternating logistic regressions with orthogonalized residuals</title><link>https://maryryan.netlify.app/publication/meng-orth-2023/</link><pubDate>Sat, 01 Jul 2023 00:00:00 +0000</pubDate><guid>https://maryryan.netlify.app/publication/meng-orth-2023/</guid><description/></item><item><title>Maximin optimal cluster randomized designs for assessing treatment effect heterogeneity</title><link>https://maryryan.netlify.app/publication/ryan-maximin-2023/</link><pubDate>Tue, 20 Jun 2023 00:00:00 +0000</pubDate><guid>https://maryryan.netlify.app/publication/ryan-maximin-2023/</guid><description/></item><item><title>A scoping review described diversity in methods of randomization and reporting of baseline balance in stepped-wedge cluster randomized trials</title><link>https://maryryan.netlify.app/publication/nevins-sw-crt-review1-2023/</link><pubDate>Mon, 01 May 2023 00:00:00 +0000</pubDate><guid>https://maryryan.netlify.app/publication/nevins-sw-crt-review1-2023/</guid><description/></item><item><title>Sequential Sampling in Prospective Observational Studies</title><link>https://maryryan.netlify.app/publication/ryan-gillen-aoas-2022/</link><pubDate>Fri, 03 Mar 2023 00:00:00 +0000</pubDate><guid>https://maryryan.netlify.app/publication/ryan-gillen-aoas-2022/</guid><description/></item><item><title>Reasons for undergoing amyloid imaging among cognitively unimpaired older adults</title><link>https://maryryan.netlify.app/publication/ryan-amyloidreasons-2021/</link><pubDate>Tue, 06 Jul 2021 00:00:00 +0000</pubDate><guid>https://maryryan.netlify.app/publication/ryan-amyloidreasons-2021/</guid><description/></item><item><title>Using Direct-to-Consumer Genetic Testing Results to Accelerate Alzheimer Disease Clinical Trial Recruitment</title><link>https://maryryan.netlify.app/publication/dtc-c2c-2020/</link><pubDate>Wed, 14 Oct 2020 00:00:00 +0000</pubDate><guid>https://maryryan.netlify.app/publication/dtc-c2c-2020/</guid><description/></item><item><title>Is Reluctance to Share Alzheimer’s Disease Biomarker Status with a Study Partner a Barrier to Preclinical Trial Recruitment?</title><link>https://maryryan.netlify.app/publication/cox-biomarker-barrier-2020/</link><pubDate>Sat, 27 Jun 2020 00:00:00 +0000</pubDate><guid>https://maryryan.netlify.app/publication/cox-biomarker-barrier-2020/</guid><description/></item><item><title>Variance estimation for the Kappa statistic in the presence of clustered data and heterogeneous observations</title><link>https://maryryan.netlify.app/publication/ryan-spotnitz-gillen-2020/</link><pubDate>Mon, 16 Mar 2020 00:00:00 +0000</pubDate><guid>https://maryryan.netlify.app/publication/ryan-spotnitz-gillen-2020/</guid><description/></item><item><title>A preliminary study of clinical trial enrollment decisions among people with Mild Cognitive Impairment and their study partners</title><link>https://maryryan.netlify.app/publication/cox-mci-2019/</link><pubDate>Sun, 03 Nov 2019 00:00:00 +0000</pubDate><guid>https://maryryan.netlify.app/publication/cox-mci-2019/</guid><description/></item><item><title>Participant and Study Partner Prediction and Identification of Cognitive Impairment in Preclinical Alzheimer's Disease- Study Partner vs. Participant Accuracy</title><link>https://maryryan.netlify.app/publication/sp-info-2019/</link><pubDate>Fri, 18 Oct 2019 00:00:00 +0000</pubDate><guid>https://maryryan.netlify.app/publication/sp-info-2019/</guid><description/></item></channel></rss>